SpyGlass Pharma, Inc.
SGPFigures shown here come from public SEC filings. Dates beside each section show the available history.
How SpyGlass Pharma, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 2 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Feb 11, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among SpyGlass Pharma, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-09 · RA Capital Healthcare Fund LP: Larger than all 15 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2026-02-09–2026-02-09: 16 event(s) across 14 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-09 | Florence Anthony A. Jr. · 10% owner | Common Stock | P — Open market or private purchase | +937,500 | 16.00 | SEC filing |
| 2026-02-09 | Yang Rick · 10% owner | Common Stock | P — Open market or private purchase | +937,500 | 16.00 | SEC filing |
| 2026-02-09 | Behbahani Ali · Director, 10% owner | Common Stock | P — Open market or private purchase | +937,500 | 16.00 | SEC filing |
| 2026-02-09 | Chang Carmen · 10% owner | Common Stock | P — Open market or private purchase | +937,500 | 16.00 | SEC filing |
| 2026-02-09 | Mathers Edward T · 10% owner | Common Stock | P — Open market or private purchase | +937,500 | 16.00 | SEC filing |
| 2026-02-09 | Khan Bilal Arshad · Director | Common Stock | P — Open market or private purchase | +115,000 | 16.00 | SEC filing |
| 2026-02-09 | Khan Bilal Arshad · Director | Common Stock | P — Open market or private purchase | +20,000 | 16.00 | SEC filing |
| 2026-02-09 | Walker Paul Edward · 10% owner | Common Stock | P — Open market or private purchase | +937,500 | 16.00 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-02-09 | BASKETT FOREST · 10% owner | Series D Preferred Stock | C — Conversion of derivative security | −737,962 | SEC filing |
| 2026-02-09 | Yang Rick · 10% owner | Common Stock | C — Conversion of derivative security | +1,370,168 | SEC filing |
| 2026-02-09 | Nielsen Kirk G. · Director | Series C-2 Preferred Stock | C — Conversion of derivative security | −3,142,015 | SEC filing |
| 2026-02-09 | Behbahani Ali · Director, 10% owner | Series C-2 Preferred Stock | C — Conversion of derivative security | −1,370,168 | SEC filing |
| 2026-02-09 | SANDELL SCOTT D · 10% owner | Common Stock | C — Conversion of derivative security | +737,962 | SEC filing |
| 2026-02-09 | Mathers Edward T · 10% owner | Series C-1 Preferred Stock | C — Conversion of derivative security | −1,370,168 | SEC filing |
| 2026-02-09 | RA Capital Healthcare Fund LP · Director, 10% owner | Series C-2 Preferred Stock | C — Conversion of derivative security | −767,294 | SEC filing |
| 2026-02-09 | Makhzoumi Mohamad · 10% owner | Series C-1 Preferred Stock | C — Conversion of derivative security | −1,370,168 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.